查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2098436

兒童醫療保健市場－2026-2032年全球市場預測

Pediatric Health Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，兒童醫療保健市場將成長至 2,162.1 億美元，複合年成長率為 8.38%。

主要市場統計數據
基準年 2025 1230.7億美元
預計年份：2026年 1317.7億美元
預測年份 2032 2162.1億美元
複合年成長率 (%) 8.38%

兒童醫療保健涵蓋從出生到青年期的整個生命歷程，包括預防保健、急性和慢性疾病管理、營養、免疫接種、心理健康、身心障礙者支持、青少年健康和兒童保護。全球龐大的兒童人口、醫療保健服務取得持續存在的不平等、非傳染性疾病風險的上升、疫苗接種率的差異、抗生素抗藥性、數位醫療的興起以及兒童和青少年心理健康日益被重視為公共衛生優先事項等因素，共同塑造了這一領域。儘管全球衛生組織的數據持續顯示，過去幾十年兒童存活率取得了顯著進步，但可預防的新生兒和五歲以下兒童死亡、營養不良、感染疾病、出生缺陷、創傷和發育障礙仍然是許多醫療保健系統面臨的主要挑戰。同時，高所得國家和日益都市化的地區也面臨著肥胖、氣喘、糖尿病、神經發育障礙、焦慮症、憂鬱症以及與螢幕使用相關的生活方式風險等挑戰帶來的日益沉重的負擔。對於醫療保健提供者、政策制定者、保險公司、醫療設備創新者、製藥相關人員和公共衛生領導者而言，兒童護理正在從孤立的治療轉向以家庭為中心、以數位驅動、以公平為中心的綜合護理模式。

兒童醫學領域的變革性變化

人口結構變化、氣候變遷帶來的健康威脅、疫情後恢復需求以及精準醫療、疫苗、診斷技術和互聯醫療的進步正在改變兒童醫療保健的模式。有證據表明，早期療育能夠改善終身健康狀況，因此醫療保健系統正將生命最初1000天、幼兒早期發展、校內健康服務和青少年福祉放在首位。儘管免疫接種計劃仍然是基礎性的，但疫苗接種率不均和錯誤訊息的傳播凸顯了建立具有韌性的基層醫療、社區參與和可靠的低溫運輸系統的重要性。氣候變遷也透過高溫暴露、空氣污染、蟲媒感染疾病、糧食不安全、流離失所和災害相關創傷等途徑改變兒童的風險狀況。由於兒童器官仍在發育、單位體重暴露率高以及高度依賴看護者，他們更容易受到這些因素的影響。同時，兒科醫療模式正朝著多學科協作的兒童醫療保健網路轉變，該網路整合了基層醫療、專科轉診、行為健康、營養、復健和社會支持。遠端醫療、遠距監測、電子健康記錄、臨床決策支援和居家照護正在改善醫療服務的連續性，尤其對患有慢性疾病或複雜疾病的兒童而言更是如此。然而，這些進步也伴隨著許多挑戰，例如隱私問題、資料互通性、數位鴻溝、人員短缺、參與兒童臨床試驗以及提供符合年齡和文化背景的醫療服務的需求。

人工智慧對兒童醫療保健的累積影響

人工智慧正透過臨床決策支援、醫學影像解讀、早期警報系統、藥物安全、人群健康分析、遠距監測、分診和個人化診療路徑等方式，對兒童醫療保健產生日益顯著的影響。在兒童，人工智慧有助於識別住院兒童病情惡化、預警敗血症風險、支持放射科和眼科的工作流程、檢測發育和行為模式、促進疫苗接種，並對氣喘和糖尿病等慢性疾病的風險進行分層。人工智慧驅動的自然語言處理減輕了病歷記錄的負擔，並支持對非結構化臨床記錄的分析。同時，預測分析有助於公共衛生團隊實施有關營養、免疫接種以及婦幼保健的適當干預措施。將人工智慧整合到臨床管理的工作流程中，而不是將其作為獨立工具使用，以最大限度地發揮其累積效應。當人工智慧引入兒童醫療保健時，必須採取特殊的安全措施，因為兒童的生理功能、生長階段、疾病症狀和藥物劑量均與成人不同，而且演算法的表現也可能因年齡、性別、種族、社會經濟地位、殘疾狀況和地區而異。因此，在兒童醫療保健中負責任地實施人工智慧需要檢驗的兒童資料集、偏差測試、透明的模型管治、臨床醫生的監督、可解釋性、對知情同意和批准的考慮、網路安全以及遵守兒童資料保護標準。人工智慧最適合作為輔助功能，在維護小兒科臨床判斷和家庭信任的同時，增強預防性護理、減少不必要的延誤並改善護理協調。

兒童醫療保健的關鍵區域見解

亞太地區兒童人口眾多，都市化迅速，免疫基礎設施不斷完善，但高所得、中等收入、農村和偏遠社區在醫療保健服務獲取方面存在顯著差異，因此該地區對兒童醫療保健至關重要。該地區各國正在加強婦幼保健計畫、新生兒篩檢、營養改善措施和數位健康平台建設，同時也正在應對空氣污染、登革熱、結核病、部分地區營養不良以及都市區兒童肥胖率上升等挑戰。北美地區擁有先進的兒童專科護理、完善的新生兒和重症監護系統、廣泛的疫苗接種計劃以及對行為健康整合的不斷投入，但仍面臨著由保險覆蓋範圍、區域因素、種族、收入、原住民健康差異以及兒童心理健康專業人員短缺等造成的差距。在拉丁美洲，儘管兒童存活率和免疫基礎設施取得了顯著改善，但兒童健康優先事項仍然受到社會經濟差異、營養轉型、青少年懷孕、感染疾病爆發以及獲得專科醫療服務機會不均等因素的影響。歐洲受益於完善的公共衛生體系、許多國家普及或接近普及的醫療保健、成熟的免疫規劃和健全的兒童保護框架，但也面臨著心理健康、與移民相關的醫療保健需求、抗生素抗藥性以及兒童專科醫療服務等待時間過長等問題。在中東，尤其是在高所得的醫療保健體系中，兒童醫院容量、遺傳醫學、新生兒護理和國家預防計畫正在推進。同時，該地區也在應對近親繁殖相關的遺傳疾病、糖尿病風險、受衝突影響兒童的健康以及流離失所者獲得醫療服務機會不均等挑戰。非洲在改善全球兒童健康方面發揮核心作用，因為許多非洲國家仍然面臨著新生兒死亡、瘧疾、肺炎、腹瀉、營養不良、愛滋病毒感染風險以及疫苗可預防疾病的沉重負擔。然而，社區衛生工作者、擴大的免疫接種計劃、營養計劃、婦幼保健舉措以及擴大使用行動醫療醫療解決方案來覆蓋服務不足的人群，都為改善兒童健康帶來了積極影響。

影響兒童健康優先事項的關鍵群體特定見解

東協兒童健康優先事項受快速都市化、收入水平差異、全民健康覆蓋（UHC）不斷擴大以及感染疾病和非傳染性疾病雙重風險的影響。儘管免疫接種、婦幼保健、登革熱預防、營養和學校健康仍然是該地區的重點，但數位醫療和社區醫療正在擴大服務範圍，惠及島嶼、農村和邊境社區。海灣合作理事會（GCC）國家擁有完善的兒童醫療基礎設施、較高的數位醫療普及率和健全的專科醫療體系。政策重點包括預防兒童肥胖、降低糖尿病風險、基因篩檢、罕見疾病管理和高品質的新生兒護理服務。歐盟透過監管標準協調、跨境公共衛生合作、疫苗安全監測、兒童權利框架以及應對癌症、罕見疾病、兒童健康和抗生素抗藥性等舉措，支持兒科醫療保健。金磚國家（BRICS）的兒童醫療保健體系各不相同，這些國家擁有大規模的兒童人口、不斷擴大的國家醫療保健體系、大規模的免疫接種計劃，並且對價格合理的藥品、診斷和數位醫療模式有著很高的需求。這些國家的優先事項包括降低可預防的兒童死亡率、改善基層醫療、治理空氣污染以及應對兒童慢性疾病的過渡。儘管七國集團（G7）國家通常擁有完善的兒童醫學研究體系、強大的專家網路和成熟的公共衛生監測系統，但它們也面臨著兒童醫護人員短缺、精神健康危機、疫苗接種猶豫、健康差距和成本壓力等問題。北約成員國由於與許多高所得國家的醫療保健系統存在重疊，因此越來越傾向於從韌性、人道主義和應急準備的角度看待兒童健康，尤其是在流離失所兒童、軍人家庭、災害應對、感染疾病防控以及危機期間保護兒童醫療基礎設施等觀點。

各國在兒童健康方面的主要見解

美國在兒童專科和研究能力方面處於世界領先地位，在新生兒重症監護、兒童腫瘤、罕見疾病和數位醫療領域擁有強大的實力，但在母嬰健康結果、兒童心理健康服務、農村地區醫療服務以及醫療費用可負擔性方面仍存在持續的不平等現象。加拿大優先發展公共醫療、兒童免疫接種、解決原住民兒童的健康差距以及心理健康支持，但地理距離和人員短缺影響了北部和偏遠社區的醫療服務取得。墨西哥正在加強初級保健、免疫接種和營養計劃，同時致力於解決兒童肥胖、糖尿病風險以及都市區人口醫療服務取得的差距。巴西擁有完善的公共衛生基礎設施和豐富的免疫接種及社區衛生經驗，其優先關注登革熱、先天性性行為感染、營養、新生兒護理以及區域醫療服務獲取方面的差距。英國受益於國家醫療服務體系 (NHS) 和全面的兒童臨床指南，但也面臨著許多挑戰，例如候診名單過長、兒童心理健康需求、呼吸系統疾病負擔沉重以及健康差距等問題。德國擁有健全的兒童醫療保健體系、法定醫療保險和完善的醫院基礎設施，並致力於整合數位醫療、開展預防性健康檢查、提高疫苗接種率以及改善青少年心理健康。法國在提供全民健保的同時，也提供全面的婦幼保健服務和兒童免疫接種政策，並同時關注心理健康、預防肥胖和醫療人員配備等議題。俄羅斯兒童醫療保健的優先事項包括新生兒護理、免疫接種、獲得當地醫療服務以及在廣大地區進行慢性病管理。義大利和西班牙都擁有完善的公共衛生體系和深厚的家庭醫學及兒童醫學傳統，目前兩國優先關注醫療衛生人員老齡化、青少年心理健康、預防肥胖以及確保各地區醫療服務的公平獲取。中國正在擴大婦幼保健服務、兒童醫院容量、疫苗接種率，並引入數位醫療，同時也在努力解決都市區差距、空氣污染、近視、肥胖以及兒童短缺等問題。印度是世界上兒童人口最多的國家之一，在免疫接種、新生兒護理、營養和數位公共衛生平台等領域取得了進展，但營養不良、貧血、肺炎、腹瀉、結核病以及優質醫療服務取得方面的差距仍然是亟待解決的重大問題。日本擁有先進的兒童醫療體系、較長的預期壽命以及完善的免疫接種和新生兒護理體系，但同時也越來越關注出生率下降、發育支持、心理健康以及對有複雜需求兒童的長期護理等問題。澳洲優先考慮全民健保、免疫接種、原住民兒童健康、農村地區醫療保健服務以及數位化醫療服務，並將心理健康、肥胖、過敏和氣候變遷相關的健康風險列為重點領域。韓國擁有先進的醫院基礎設施、數位化醫療能力和完善的預防性醫療保健項目，但也面臨出生率下降、青少年心理健康、過敏和氣喘治療以及兒童醫護人員隊伍永續性等挑戰。

為兒童醫療產業的領導者提供的實用建議

產業領導者應優先考慮能夠反映兒童發展、生理、行為和社會需求的兒童專屬創新，而不是簡單地套用以成人為中心的模式。應先加強初級和預防保健，包括免疫接種支持、早期篩檢、營養計劃、發育檢驗和以家庭為中心的教育。數位化和人工智慧解決方案的設計應充分考慮兒童驗證、隱私保護措施、透明的管治以及與臨床醫生工作流程的整合。各機構應投資於確保公平獲取醫療服務的策略，包括本地遠端醫療、多語言支援、校內護理協調、社區衛生工作者模式以及針對基本兒童藥品、診斷試劑和醫療設備的價格最佳化計劃。兒童心理健康護理應整合到初級保健、急診醫學、學校和數位管道中，並採用循序漸進的護理模式和早期療育途徑。此外，產業相關人員應透過利用符合倫理的受試者招募、符合年齡的知情同意流程、分散式臨床試驗工具和真實世界數據（REW）收集，擴大其在兒童臨床研究中的參與。韌性規劃變得日益重要，需要為感染疾病爆發、氣候災害、供應鏈中斷、人道危機以及與疫苗信任相關的挑戰做好準備。能夠將創新與兒童安全、證據生成、監管合規、公平性和看護者信心相協調的領導者，將更有能力改善整個兒童醫療保健系統的成果。

調查方法

本執行摘要採用二手研究途徑，以來自權威公共衛生、臨床、監管和多邊組織的檢驗且有數據支持的資訊來源為中心。調查方法包括對全球和區域健康指標、兒童疾病負擔證據、免疫和營養數據、兒童和青少年心理健康研究、數位健康和​​人工智慧管治指南以及權威機構政策文件的審查。透過對流行病學模式、醫療服務趨勢、技術應用、監管重點以及區域、國家集團和特定國家醫療保健系統的公平性考量進行定性分析，整合了相關見解。本分析避免了市場規模計算、市場佔有率估算、預測和未經證實的商業性聲明。重點在於交叉檢驗來自可靠資訊來源的證據，識別兒童醫療保健系統的通用主題，並將這些見解轉化為對醫療保健提供者、政策制定者、保險公司、技術開發商、製藥相關人員和公共衛生決策者可行的建議。限制包括數據時效性、報告品質、醫療保健系統透明度以及各國之間的可比較性等方面的差異。這些問題在心理健康、殘疾和社區服務取得等領域尤為突出。

結論

兒童醫療保健正處於關鍵時刻，隨著預防醫學、數位轉型、人工智慧驅動的決策支援、心理健康整合和健康公平的融合，兒童和青少年醫療保健正在被重新定義。最迫切的優先事項仍然是降低可預防的新生兒和兒童死亡率、消除免疫接種和營養方面的差距、改善獲得高品質初級和專科醫療服務的途徑，以及應對日益嚴重的慢性病和行為健康問題。儘管區域和國家之間存在顯著差異，通用的挑戰包括建立具有韌性的醫療保健系統、建立基於信任的社區參與、培訓兒童醫療保健專業人員、實施負責任的技術以及為弱勢兒童提供更強力的保護。人工智慧、遠端醫療診斷和真實世界數據，在嚴格的檢驗、合乎倫理的管治和包容性的獲取途徑的支持下，可以改善兒童醫療保健的結果。兒童醫學的未來將由利益相關者塑造，他們將循證醫學、以家庭為中心的護理、公共衛生預防和以兒童為先的創新相結合，為世界各地的相關人員提供更安全、更公平和更永續的醫療服務。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章兒童醫療保健市場：依產品類型分類

  • 醫療設備
    • 醫療影像設備
    • 監控設備
    • 手術器械
  • 診斷
    • 分子診斷
    • 照護現場
  • 製藥
    • 生物製劑
    • 低分子
    • 疫苗

第8章兒童醫療保健市場：依疾病類型分類

  • 內分泌
  • 消化器官系統
  • 感染疾病
    • 細菌
      • 葡萄球菌感染疾病
      • 鏈球菌感染疾病
    • 寄生
    • 病毒性的
      • 呼吸道融合細胞病毒
      • 輪狀病毒
  • 神經病學
  • 呼吸系統

第9章：兒童醫療保健市場：依年齡層別分類

  • 青春期
    • 青春期早期
    • 青春期後期
  • 孩子們
    • 幼兒期
    • 童年中期
  • 嬰兒
  • 嬰兒

第10章：兒童醫療保健市場：依最終用戶分類

  • 診所
    • 全科診所
    • 小兒科診所
  • 居家照護
  • 醫院
    • 綜合醫院
    • 兒童醫院
  • 專業醫療中心

第11章兒童醫療保健市場：按分銷管道分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第12章兒童醫療保健市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章兒童醫療保健市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章兒童醫療保健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Alembic Pharmaceuticals Limited
  • Alkem Laboratories Limited
  • Atom Medical Corporation
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • BrainChild Bio Inc
  • Cardinal Health Inc
  • Day One Biopharmaceuticals Inc
  • Edwards Lifesciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Fritz Stephan GmbH
  • GE HealthCare Technologies Inc
  • Hamilton Medical AG
  • Intas Pharmaceuticals Limited
  • Koninklijke Philips NV
  • Lupin Limited
  • Masimo Corporation
  • Medtronic plc
  • Ningbo David Medical Device Co Ltd
  • Oncoheroes Biosciences Inc
  • Phoenix Medical Systems Pvt Ltd
  • Renaissance Pharma Ltd
  • Sarepta Therapeutics Inc
  • Sensorion SA
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-62667ADF93FE

The Pediatric Health Market is projected to grow by USD 216.21 billion at a CAGR of 8.38% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 123.07 billion
Estimated Year [2026] USD 131.77 billion
Forecast Year [2032] USD 216.21 billion
CAGR (%) 8.38%

Pediatric health encompasses preventive care, acute and chronic disease management, nutrition, immunization, mental health, disability support, adolescent health, and child protection across the life course from birth to young adulthood. The sector is shaped by a large global child population, persistent inequities in access to care, rising noncommunicable disease risks, vaccine coverage gaps, antimicrobial resistance, digital health adoption, and increasing recognition of child and adolescent mental health as a public health priority. Data from global health agencies consistently show that substantial progress has been made in child survival over recent decades, yet preventable neonatal and under-five deaths, malnutrition, infectious diseases, congenital conditions, injuries, and developmental disorders remain major challenges in many health systems. At the same time, high-income and urbanizing settings face growing burdens related to obesity, asthma, diabetes, neurodevelopmental conditions, anxiety, depression, and screen-related lifestyle risks. For healthcare providers, policymakers, payers, device innovators, pharmaceutical stakeholders, and public health leaders, pediatric health is moving from episodic treatment toward integrated, family-centered, digitally enabled, and equity-focused models of care.

Transformative Shifts in the Pediatric Health Landscape

The pediatric health landscape is being transformed by demographic shifts, climate-related health threats, post-pandemic recovery needs, and advances in precision medicine, vaccines, diagnostics, and connected care. Health systems are prioritizing the first 1,000 days of life, early childhood development, school-based health services, and adolescent wellbeing because evidence links early intervention with improved lifelong health outcomes. Immunization programs remain a cornerstone, but uneven vaccine coverage and misinformation have increased the need for resilient primary care, community engagement, and reliable cold-chain systems. Climate change is also reshaping pediatric risk profiles through heat exposure, air pollution, vector-borne diseases, food insecurity, displacement, and disaster-related trauma, with children facing disproportionate vulnerability due to developing organs, higher exposure per body weight, and dependence on caregivers. Meanwhile, the care model is shifting toward multidisciplinary pediatric networks that combine primary care, specialty referrals, behavioral health, nutrition, rehabilitation, and social support. Telehealth, remote monitoring, electronic health records, clinical decision support, and home-based care are improving continuity, particularly for children with chronic or complex conditions. However, these advances are accompanied by challenges around privacy, data interoperability, digital exclusion, workforce shortages, pediatric clinical trial participation, and the need for age-appropriate, culturally responsive care.

Cumulative Impact of Artificial Intelligence on Pediatric Health

Artificial intelligence is increasingly influencing pediatric health through clinical decision support, medical imaging interpretation, early warning systems, medication safety, population health analytics, remote monitoring, triage, and personalized care pathways. In pediatrics, AI can help identify deterioration in hospitalized children, flag sepsis risk, support radiology and ophthalmology workflows, detect developmental or behavioral patterns, improve vaccine outreach, and stratify risk for chronic conditions such as asthma or diabetes. AI-enabled natural language processing can also reduce documentation burden and support analysis of unstructured clinical notes, while predictive analytics can help public health teams target nutrition, immunization, and maternal-child health interventions. The cumulative impact is strongest when AI is embedded into clinically governed workflows rather than used as a standalone tool. Pediatric deployment requires particular safeguards because children's physiology, growth trajectories, disease presentation, and medication dosing differ from adults, and algorithmic performance may vary by age, sex, ethnicity, socioeconomic status, disability, and geography. Responsible AI adoption in pediatric healthcare therefore depends on validated pediatric datasets, bias testing, transparent model governance, clinician oversight, explainability, consent and assent considerations, cybersecurity, and compliance with child data protection standards. AI is best positioned as an augmenting capability that strengthens preventive care, reduces avoidable delays, and improves care coordination while preserving pediatric clinical judgment and family trust.

Key Regional Insights Across Pediatric Health

Asia-Pacific is a pivotal region for pediatric health due to its large child population, rapid urbanization, expanding immunization infrastructure, and wide variation in access between high-income, middle-income, rural, and remote communities. Countries across the region are strengthening maternal and child health programs, newborn screening, nutrition initiatives, and digital health platforms, while also addressing air pollution, dengue, tuberculosis, undernutrition in some areas, and rising childhood obesity in urban settings. North America is characterized by advanced pediatric specialty care, strong neonatal and critical care capacity, broad vaccine programs, and growing investment in behavioral health integration, yet it continues to face disparities linked to insurance coverage, geography, race, income, Indigenous health inequities, and shortages in pediatric mental health professionals. Latin America has made major improvements in child survival and immunization infrastructure, but pediatric health priorities remain shaped by socioeconomic inequality, nutrition transition, adolescent pregnancy, infectious disease outbreaks, and uneven access to specialty services. Europe benefits from well-established public health systems, universal or near-universal coverage in many countries, mature vaccination programs, and strong child protection frameworks, while facing concerns around mental health, migration-related care needs, antimicrobial resistance, and waiting times for specialized pediatric services. The Middle East is advancing pediatric hospital capacity, genetic medicine, neonatal care, and national prevention programs, particularly in higher-income health systems, while the region also manages challenges related to consanguinity-linked genetic disorders, diabetes risk, conflict-affected child health, and access gaps for displaced populations. Africa remains central to global pediatric health improvement because many countries carry high burdens of neonatal mortality, malaria, pneumonia, diarrhea, malnutrition, HIV exposure, and vaccine-preventable diseases; however, progress is being supported by community health workers, expanded immunization, nutrition programs, maternal-child health initiatives, and growing use of mobile health solutions to reach underserved populations.

Key Group Insights Shaping Pediatric Health Priorities

ASEAN pediatric health priorities are defined by rapid urbanization, diverse income levels, expanding universal health coverage efforts, and the dual burden of infectious disease and noncommunicable disease risk. The region continues to focus on immunization, maternal-child health, dengue control, nutrition, and school health, while digital health and community-based care are improving service reach across island, rural, and border communities. The GCC has advanced pediatric infrastructure, high uptake of digital health, and strong capacity for specialized care, with policy emphasis on childhood obesity prevention, diabetes risk reduction, genetic screening, rare disease management, and high-quality neonatal services. The European Union supports pediatric health through coordinated regulatory standards, cross-border public health collaboration, vaccine safety monitoring, child rights frameworks, and initiatives addressing cancer, rare diseases, mental health, and antimicrobial resistance. BRICS countries represent a broad spectrum of pediatric health systems, combining large child populations, expanding domestic healthcare capacity, major immunization programs, and high demand for affordable medicines, diagnostics, and digital care models; their priorities include reducing preventable child mortality, improving primary care, addressing air pollution, and managing the shift toward chronic pediatric diseases. G7 countries typically have advanced pediatric research ecosystems, strong specialty networks, and established public health surveillance, but they are also confronting pediatric workforce shortages, mental health crises, vaccine hesitancy, health inequities, and cost pressures. NATO member states overlap with many high-income health systems and increasingly view child health through resilience, humanitarian, and emergency preparedness lenses, particularly for displaced children, military families, disaster response, infectious disease readiness, and protection of pediatric care infrastructure during crises.

Key Country Insights in Pediatric Health

The United States has leading pediatric specialty and research capacity, with strong neonatal intensive care, pediatric oncology, rare disease, and digital health capabilities, yet it faces persistent inequities in maternal-child outcomes, pediatric mental health access, rural care availability, and affordability. Canada emphasizes publicly funded healthcare, child vaccination, Indigenous child health equity, and mental health support, while geographic distance and workforce constraints affect access in northern and remote communities. Mexico is strengthening primary care, vaccination, and nutrition programs while addressing childhood obesity, diabetes risk, and access variation between urban and rural populations. Brazil has extensive public health infrastructure and experience in immunization and community health, with priorities including dengue, congenital infections, nutrition, neonatal care, and regional access disparities. The United Kingdom benefits from a national health system and strong pediatric clinical guidance, but faces pressure from waiting lists, child mental health demand, respiratory illness burden, and health inequalities. Germany has robust pediatric specialty care, statutory health coverage, and strong hospital infrastructure, while focusing on digital health integration, preventive checkups, vaccination uptake, and adolescent mental health. France combines universal access with strong maternal-child protection services and pediatric vaccination policy, while addressing mental health, obesity prevention, and workforce distribution. Russia's pediatric priorities include neonatal care, vaccination, regional service accessibility, and chronic disease management across a vast geography. Italy and Spain both rely on established public health systems and strong family medicine and pediatric care traditions, with current priorities around aging health workforce pressures, adolescent mental health, obesity prevention, and equitable access across regions. China has expanded maternal and child health services, pediatric hospital capacity, vaccination coverage, and digital health adoption, while managing urban-rural disparities, air pollution exposure, myopia, obesity, and the need for more pediatric specialists. India carries one of the world's largest pediatric populations and has made progress in immunization, neonatal care, nutrition, and digital public health platforms, while undernutrition, anemia, pneumonia, diarrhea, tuberculosis, and uneven access to quality care remain significant concerns. Japan has advanced pediatric care, high life expectancy, strong vaccination and neonatal systems, and increasing focus on low birth rates, developmental support, mental health, and long-term care for children with complex needs. Australia emphasizes universal coverage, immunization, Indigenous child health, rural access, and digital care delivery, with priorities including mental health, obesity, allergies, and climate-related health risks. South Korea has sophisticated hospital infrastructure, digital health capabilities, and strong preventive care programs, while addressing low birth rates, adolescent mental health, allergy and asthma care, and pediatric workforce sustainability.

Actionable Recommendations for Pediatric Health Industry Leaders

Industry leaders should prioritize pediatric-specific innovation that reflects children's developmental, physiological, behavioral, and social needs rather than adapting adult-centered models. Action should begin with strengthening primary and preventive care through immunization support, early screening, nutrition programs, developmental surveillance, and family-centered education. Digital and AI-enabled solutions should be designed with pediatric validation, privacy-by-design safeguards, transparent governance, and integration into clinician workflows. Organizations should invest in equitable access strategies, including rural telehealth, multilingual engagement, school-based care partnerships, community health worker models, and affordability programs for essential pediatric medicines, diagnostics, and devices. Pediatric mental health should be embedded across primary care, emergency care, schools, and digital channels, with stepped-care models and early intervention pathways. Industry stakeholders should also expand pediatric clinical research participation using ethical recruitment, age-appropriate consent processes, decentralized trial tools, and real-world evidence generation. Resilience planning is increasingly important, requiring preparedness for infectious disease surges, climate disasters, supply chain disruptions, humanitarian crises, and vaccine confidence challenges. Leaders that align innovation with child safety, evidence generation, regulatory compliance, equity, and caregiver trust will be best positioned to improve outcomes across pediatric healthcare systems.

Research Methodology

This executive summary is developed using a secondary research approach centered on verified and data-backed sources from recognized public health, clinical, regulatory, and multilateral institutions. The methodology includes review of global and regional health indicators, pediatric disease burden evidence, immunization and nutrition data, child and adolescent mental health research, digital health and AI governance guidance, and policy documentation from authoritative agencies. Insights are synthesized through qualitative analysis of epidemiological patterns, healthcare delivery trends, technology adoption, regulatory priorities, and equity considerations across regions, country groups, and selected national health systems. The analysis avoids market sizing, market share estimation, forecasting, and unsupported commercial claims. Emphasis is placed on triangulating evidence from credible sources, identifying consistent themes across pediatric health systems, and translating findings into practical implications for healthcare providers, policymakers, payers, technology developers, pharmaceutical stakeholders, and public health decision-makers. Limitations include variation in data recency, reporting quality, health system transparency, and comparability across countries, particularly in areas such as mental health, disability, and community-level service access.

Conclusion

Pediatric health is entering a decisive phase in which preventive care, digital transformation, AI-enabled decision support, mental health integration, and health equity are converging to redefine child and adolescent care. The most urgent priorities remain reducing preventable neonatal and child deaths, closing immunization and nutrition gaps, improving access to quality primary and specialty care, and addressing the rising burden of chronic and behavioral health conditions. Regional and country-level differences are substantial, but common themes include the need for resilient health systems, trusted community engagement, pediatric workforce development, responsible technology adoption, and stronger protection for vulnerable children. Artificial intelligence, telehealth, connected diagnostics, and real-world data can improve pediatric outcomes when supported by rigorous validation, ethical governance, and inclusive access. The future of pediatric health will be shaped by stakeholders that combine evidence-based medicine, family-centered care, public health prevention, and child-first innovation to deliver safer, more equitable, and more sustainable outcomes for children worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pediatric Health Market, by Product Type

  • 7.1. Introduction
  • 7.2. Devices
    • 7.2.1. Imaging Devices
    • 7.2.2. Monitoring Devices
    • 7.2.3. Surgical Instruments
  • 7.3. Diagnostics
    • 7.3.1. Molecular Diagnostics
    • 7.3.2. Point Of Care
  • 7.4. Drugs
    • 7.4.1. Biologics
    • 7.4.2. Small Molecule
    • 7.4.3. Vaccines

8. Pediatric Health Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Endocrine
  • 8.3. Gastrointestinal
  • 8.4. Infectious
    • 8.4.1. Bacterial
      • 8.4.1.1. Staphylococcal Infections
      • 8.4.1.2. Streptococcal Infections
    • 8.4.2. Parasitic
    • 8.4.3. Viral
      • 8.4.3.1. Respiratory Syncytial Virus
      • 8.4.3.2. Rotavirus
  • 8.5. Neurology
  • 8.6. Respiratory

9. Pediatric Health Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adolescents
    • 9.2.1. Early Adolescents
    • 9.2.2. Late Adolescents
  • 9.3. Children
    • 9.3.1. Early Childhood
    • 9.3.2. Middle Childhood
  • 9.4. Infants
  • 9.5. Toddlers

10. Pediatric Health Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
    • 10.2.1. Multi Specialty Clinics
    • 10.2.2. Pediatric Clinics
  • 10.3. Home Care
  • 10.4. Hospitals
    • 10.4.1. General Hospitals
    • 10.4.2. Pediatric Hospitals
  • 10.5. Specialty Centers

11. Pediatric Health Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Hospital Pharmacies
  • 11.3. Online Pharmacies
  • 11.4. Retail Pharmacies

12. Pediatric Health Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Pediatric Health Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pediatric Health Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Alembic Pharmaceuticals Limited
  • 16.3. Alkem Laboratories Limited
  • 16.4. Atom Medical Corporation
  • 16.5. Baxter International Inc
  • 16.6. Becton, Dickinson and Company
  • 16.7. Boston Scientific Corporation
  • 16.8. BrainChild Bio Inc
  • 16.9. Cardinal Health Inc
  • 16.10. Day One Biopharmaceuticals Inc
  • 16.11. Edwards Lifesciences Corporation
  • 16.12. F. Hoffmann-La Roche Ltd
  • 16.13. Fritz Stephan GmbH
  • 16.14. GE HealthCare Technologies Inc
  • 16.15. Hamilton Medical AG
  • 16.16. Intas Pharmaceuticals Limited
  • 16.17. Koninklijke Philips N.V.
  • 16.18. Lupin Limited
  • 16.19. Masimo Corporation
  • 16.20. Medtronic plc
  • 16.21. Ningbo David Medical Device Co Ltd
  • 16.22. Oncoheroes Biosciences Inc
  • 16.23. Phoenix Medical Systems Pvt Ltd
  • 16.24. Renaissance Pharma Ltd
  • 16.25. Sarepta Therapeutics Inc
  • 16.26. Sensorion SA
  • 16.27. Siemens Healthineers AG
  • 16.28. Stryker Corporation
  • 16.29. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEDIATRIC HEALTH MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PEDIATRIC HEALTH MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SMALL MOLECULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SMALL MOLECULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SMALL MOLECULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOCRINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOCRINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOCRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INFECTIOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INFECTIOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INFECTIOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STAPHYLOCOCCAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STAPHYLOCOCCAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STAPHYLOCOCCAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STREPTOCOCCAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STREPTOCOCCAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STREPTOCOCCAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARASITIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARASITIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARASITIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VIRAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VIRAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VIRAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY SYNCYTIAL VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROTAVIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ROTAVIRUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROTAVIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ADOLESCENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ADOLESCENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ADOLESCENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EARLY ADOLESCENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EARLY ADOLESCENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EARLY ADOLESCENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LATE ADOLESCENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LATE ADOLESCENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LATE ADOLESCENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CHILDREN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CHILDREN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CHILDREN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EARLY CHILDHOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EARLY CHILDHOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EARLY CHILDHOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MIDDLE CHILDHOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MIDDLE CHILDHOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MIDDLE CHILDHOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INFANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INFANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INFANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TODDLERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TODDLERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TODDLERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MULTI SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MULTI SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MULTI SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PEDIATRIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PEDIATRIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PEDIATRIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PEDIATRIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PEDIATRIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PEDIATRIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. GCC PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. GCC PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 255. GCC PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. GCC PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 257. GCC PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. GCC PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 260. GCC PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. GCC PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. G7 PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. G7 PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 300. G7 PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 304. G7 PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 305. G7 PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 306. G7 PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 307. G7 PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 308. G7 PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. G7 PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. G7 PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. NATO PEDIATRIC HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 313. NATO PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. NATO PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. NATO PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 319. NATO PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 320. NATO PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 321. NATO PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 322. NATO PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 323. NATO PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 324. NATO PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. NATO PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 326. NATO PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 327. NATO PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 328. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. CANADA PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. CANADA PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 358. CANADA PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 359. CANADA PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 360. CANADA PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 361. MEXICO PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 362. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 364. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 365. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 366. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 367. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 368. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 369. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
  • TABLE 370. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 371. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ADOLESCENTS, 2018-2032 (USD MILLION)
  • TABLE 372. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY CHILDREN, 2018-2032 (USD MILLION)
  • TABLE 373. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 374. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 375. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 376. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 377. BRAZIL PEDIATRIC HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 378. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 379. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 380. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 381. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 382. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 383. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS, 2018-2032 (USD MILLION)
  • TABLE 384. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 385. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY VIRAL, 2018